col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


41 Ergebisse       Seite 1

 [1] 
Bentham Science: Current Drug Targets
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2023―Jul―30 Central Effects of Ivermectin in Alleviation of Covid-19-induced Dysautonomia
2 [GO] 2023―Jul―30 Molecular Modeling Targeting Transmembrane Serine Protease 2 (TIMPRSS2) as an Alternative Drug Target Against Coronaviruses
3 [GO] 2023―Mrz―06 High-Throughput Screening for the Potential Inhibitors of SARS-CoV-2 with Essential Dynamic Behavior Zhiwei Yang, Xinhui Cai, Qiushi Ye, Yizhen Zhao, Xuhua Li, Shengli Zhang, Lei Zhang
4 [GO] 2022―Dez―06 Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology Cristina Vieira
5 [GO] 2022―Dez―06 Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion Upinder Kaur
6 [GO] 2022―Nov―17 Coagulopathy and COVID-19 Victoria A. Ploplis
7 [GO] 2022―Okt―26 COVID-19 induces Cytokine Storm and Dysfunctional Hemostasis Victoria A. Ploplis, Jermilia Charles
8 [GO] 2022―Okt―18 ACE2 as a Key Target for Treatment of COVID-19 Related Cardiovascular Diseases: Current Progress and Prospect Shuainan Li
9 [GO] 2022―Okt―18 Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis Jyotika Rajawat
10 [GO] 2022―Okt―14 Cell Entry and Unusual Replication of SARS-CoV2 Francis J. Castellino, Nathan McCann
11 [GO] 2022―Okt―12 Current Drug Targets (CDT) special issue on Covid-19 and Coagulopathy Fibrinolysis in COVID-19: impact on clot lysis and modulation of inflammation Lirlândia P. Sousa, Michelle A. Sugimoto, Luiza O. Perucci, Luciana P. Tavares, Mauro M. Teixeira
12 [GO] 2022―Okt―06 COVID-19 and Thrombosis: Clinical Aspects Tetsumei Urano, Atsushi Yasumoto, Kenji Yokoyama, Hisanori Horiuchi, Eriko Morishita, Yuko Suzuki
13 [GO] 2022―Sep―27 Tissue factor and COVID-19: an update Nigel Mackman, Ana Teresa Azevedo Sachettor
14 [GO] 2022―Sep―23 Gastrointestinal system, COVID-19 and potential mechanisms associated with coagulopathy Silvio Danese, Federica Furfaro, Roberto Gabbiadini, Ferdinando D’Amico, Alessandra Zilli, Arianna Dal Buono, et al. (+2)
15 [GO] 2022―Sep―19 Neurological Complications of SARS-CoV-2 Infection and COVID-19 Vaccines: From Molecular Mechanisms to Clinical Manifestations Manuel Yepes
16 [GO] 2022―Aug―27 Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19 Kadri Kangro, Alisa S. Wolberg, Matthew J. Flick
17 [GO] 2022―Aug―11 Central effects of Ivermectin in alleviation of Covid-19-induced dysautonomia Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Gaber El-Saber Batiha
18 [GO] 2022―Aug―05 Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology Cristina Vieira
19 [GO] 2022―Aug―05 Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion Upinder Kaur
20 [GO] 2022―Jul―15 Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology Cristina Simões e Silva
21 [GO] 2022―Jul―15 Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion Sankha Shubhra Chakrabarti
22 [GO] 2022―Jun―24 The Role of Host-Cellular Responses in COVID-19 Endothelial Dysfunction Thomas E. Moran, Daniel E. Hammers, Shaun W. Lee
23 [GO] 2022―Apr―20 Current drug targets for gut microbiota biocorrection during the SARS-CoV-2 pandemic: a systematic review. Maria V. Sankova, Vladimir N. Nikolenko, Marine V. Oganesyan, Anastasia A. Bakhmet, Lilia V. Gavryushova, Sergey V. Sankov, Mikhail Y. Sinelnikov
24 [GO] 2022―Mrz―17 Free ISG15 and protein ISGylation emerging in SARS-CoV-2 infection Angeles C. Tecalco Cruz
25 [GO] 2021―Nov―04 Potential implications of angiotensin-converting enzyme 2 blockades on neuroinflammation in SARS-CoV-2 infection Deepraj Paul, Suresh Kumar Mohankumar, Rhian S Thomas, Chai Boon Kheng, Duraiswamy Basavan
26 [GO] 2021―Okt―23 A Mechanistic Review on Plant-derived Natural Inhibitors of Human Coronaviruses with Emphasis on SARS-COV-1 and SARS-COV-2 Sai Krishna Guguloth, A R Lakshmi, Radhika Rajendran, Kaushik Rajaram, Thirunavukkarasu Chinnasamy, Jian-Dong Huang, et al. (+3)
27 [GO] 2021―Sep―07 Exploring the SARS-CoV-2 main protease (Mpro) and RdRp targets by updating current structure-based drug design utilizing co-crystals to combat COVID-19 Heena Tarannum, Sisir Nandi
28 [GO] 2021―Aug―09 Molecular Modeling Targeting Transmembrane Serine Protease 2 (TMPRSS2) as an Alternative Drug Target Against Coronaviruses Igor José dos Santos Nascimento, Edeildo Ferreira da Silva-Júnior, Thiago Mendonça de Aquino
29 [GO] 2021―Mrz―22 ACE2 as a key target for treatment of COVID-19 related cardiovascular diseases: current progress and prospect Shuainan Li, Benzhi Cai, Wenya Ma, Fan Yang, Yan Xu, Binbin Xu
30 [GO] 2021―Mrz―10 Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability utilizing Natural Agents Sisir Nandi, Harekrishna Roy, Asha Gummadi, Anil Saxena
31 [GO] 2021―Feb―16 Small-molecule antiviral agents in ongoing clinical trials for COVID-19 Çağla Begüm Apaydın, Gözde Çınar, Gökçe Cihan-Üstündağ
32 [GO] 2021―Jan―26 Role of Poly(ADP-ribose) polymerase (PARP1) in viral infection and its implication in SARS-CoV-2 pathogenesis Jyotika Rajawat, Abhishek Chandra
33 [GO] 2020―Dez―29 Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19 Amritpal Kaur, Gaurav Chaudhary, Pargat Singh, Sandeep Arora, Rajwinder Kaur
34 [GO] 2020―Dez―29 A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2 Mohana Das, Manish Kumar, Abhishek Jha, Kanchan Bharti, Shomedeep Mondal, Brahmeshwar Mishra
35 [GO] 2020―Dez―03 Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance Dinesh Singh Moirangthem, Laishram Surbala
36 [GO] 2020―Nov―27 Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection? Vivek Gupta, Madhan Kumar Murthy, Shripad Patil
37 [GO] 2020―Okt―21 Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology Cristina Vieira, Lucas Nery, Ludimila Martins, Luiz Jabour, Raphael Dias, Ana Cristina Simões e Silva
38 [GO] 2020―Okt―14 COVID-19 and Renal Diseases: An Update Letícia Bitencourt Cota, Ana Luisa Pedrosa, Stephanie Bruna Camilo Soares de Brito, Ana Cláudia Fontoura Fróes, Sarah Tayná de Carvalho, Giulio Gori Fonseca, et al. (+3)
39 [GO] 2020―Okt―07 Therapeutic Options for Treatment of COVID-19: A Review from Repur-posed Drugs to New Drug Targets Bushra Akhtar, Faqir Muhammad, Ali Sharif, Abdul Hannan
40 [GO] 2020―Sep―25 Targeting host cell proteases to prevent SARS-CoV-2 invasion Upinder Kaur, Sankha Shubhra Chakrabarti, Bisweswar Ojha, Bhairav Kumar Pathak, Amit Singh, Luciano Saso, Sasanka Chakrabarti
41 [GO] 2020―Jun―17 Facts and myths: Efficacies of repurposing chloroquine and hydroxychloroquine for the treatment of COVID-19 Md. Abdul Alim Al-Bari
 [1] 

41 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec